Patents Assigned to Shanghai Desano Chemical Pharmaceutical Co., Ltd.
  • Crystalline form of 1-(beta-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene and preparation method thereof
    Patent number: 10167306
    Abstract: The present invention relates to a crystalline form of 1-(?-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene. Specifically, it discloses a novel crystalline form of 1-(?-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene and the preparation method as well as use thereof. The novel crystalline form of 1-(?-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene provided in the present invention has the advantages such as stable physical and chemical properties, high purity, excellent reproducibility and industrial production suitability.
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: January 1, 2019
    Assignees: SHANGHAI DESANO PHARMACEUTICALS INVESTMENT CO., LTD., SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD
    Inventors: Meng Wang, Liang Zhang
  • Process for the preparation of docetaxel trihydrate
    Patent number: 7332617
    Abstract: A method to prepare Docetaxel trihydrate using the mixture of acetone and water, which provides the product with good stability, less experiment time, less exposal to light, and avoids purity decreasing. The process is simple and easy to operate.
    Type: Grant
    Filed: April 13, 2004
    Date of Patent: February 19, 2008
    Assignees: Shanghai Desano Chemical Pharmaceutical Co., Ltd., Shanghai Desano Pharmaceuticals Science & Technology Development Co., Ltd.
    Inventors: Jinliang Li, Zuwang Wu
  • Process for the preparation of docetaxel trihydrate
    Publication number: 20060217436
    Abstract: A method to prepare Docetaxel trihydrate using the mixture of acetone and water, which provides the product with good stability, less experiment time, less exposal to light, and avoids purity decreasing. The process is simple and easy to operate.
    Type: Application
    Filed: April 13, 2004
    Publication date: September 28, 2006
    Applicants: SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD, SHANGHAI DESANO PHARMACEUTICAL SCIENCE & TECHNOLOG DEVELOPEMENT CO., LTD
    Inventors: Jinliang Li, Zuwang Wu